Dr. Simantov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Pfizer Oncology
235 E42nd St
New York, NY 10017Phone+1 212-733-5545
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1990 - 1993
New York University School of MedicineClass of 1990
Publications & Presentations
PubMed
- 64 citationsEffect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell CarcinomaAly-Khan A. Lalani, Wanling Xie, David A. Braun, Marina D. Kaymakcalan, Dominick Bossé
European Urology Oncology. 2020-06-01 - 9 citationsThe Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted TherapyJustine Panian, Xun Lin, Ronit Simantov, Ithaar Derweesh, Toni K. Choueiri
Clinical Genitourinary Cancer. 2020-03-16 - 7 citationsOutcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts.Dominick Bossé, Wanling Xie, Xun Lin, Ronit Simantov, Aly-Khan A. Lalani
JCO Global Oncology. 2020-02-28
Press Mentions
Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTRFebruary 18th, 2023- Stem Cell Companies Find Gratifying NichesJune 3rd, 2022
- Gamida Cell Presents Two-Year Survival Data for GDA-201 and Resource Utilization Analysis for Omidubicel at 63rd ASH Annual MeetingDecember 13th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
